National Assessment of Early Beta-Blocker Therapy in Patients with Acute Myocardial Infarction in China 2001–2011: The China PEACE-Retrospective AMI Study

摘要

BackgroundSince 2007, clinical practice guidelines have recommended beta-blocker therapy early in the course of acute myocardial infarction (AMI) for patients who are not at high risk for complications. Our objective was to perform a national quality assessment of early beta-blocker use during hospitalization for AMI over the past decade in China.